Checkmate: Metabolic flexibility with a STING in its tail

Sci Adv. 2023 Dec 8;9(49):eadm6816. doi: 10.1126/sciadv.adm6816. Epub 2023 Dec 6.

Abstract

Inhibiting a key metabolic enzyme, ACLY, in cancer cells impacts T cell function in immunotherapy-resistant tumors and may offer a target for therapeutic treatment.

Publication types

  • Review

MeSH terms

  • Humans
  • Neoplasms* / pathology